From the genetics of rare diseases to developmental biology, from epigenetics to genome dynamics and from bioinformatics to systems biology, the MMG explores all facets of the discipline through a translational approach that focuses on the patient. The teams are particularly interested in four main families of pathologies:
Within these four departments, 150 researchers, clinicians, engineers, post docs and students seek to improve our knowledge of these diseases by combining the exploration of patient cohorts and pathophysiological models using state-of-the-art technologies within five platforms.
Closely associated with the Department of Medical Genetics of the Timone Hospital, the MMG is a joint research unit of Inserm and Aix-Marseille University. Led by Professor Nicolas LEVY, the MMG is also one of the founding members of MaRCHE, the university hospital federation dedicated to rare diseases, which is certified by A*MIDEX University Foundation, AP-HM and the Alliance des Sciences de la Vie et de la Santé.